Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1987 | 12-1986 | 12-1985 | 12-1984 | 12-1983 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 995 | 4,368 | 2,009 | 34 | 90 |
| Marketable Securities | 4,855 | 2,277 | 500 | 1 | 1,505 |
| Receivables | 0 | 250 | 0 | 0 | 0 |
| Other current assets | 283 | 32 | 83 | 8 | 73 |
| TOTAL | $6,133 | $6,926 | $2,592 | $43 | $1,668 |
| Non-Current Assets | |||||
| PPE Net | 318 | 312 | 209 | 145 | 89 |
| Investments And Advances | 0 | 0 | 0 | 0 | 1 |
| Other Non-Current Assets | 2 | 2 | 4 | 0 | 18 |
| TOTAL | $320 | $314 | $213 | $145 | $109 |
| Total Assets | $6,311 | $7,113 | $2,722 | $144 | $1,761 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 199 | 230 | 662 | 213 | 127 |
| Accrued Expenses | 72 | 166 | 0 | 0 | 0 |
| Other current liabilities | 3 | 49 | 46 | 173 | 99 |
| TOTAL | $273 | $395 | $1,310 | $409 | $225 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8 | 0 | 0 | 0 | 0 |
| TOTAL | $54 | $55 | $91 | $N/A | $N/A |
| Total Liabilities | $327 | $450 | $1,401 | $535 | $225 |
| Shareholders' Equity | |||||
| Common Shares | 99 | 98 | 84 | 75 | 75 |
| Retained earnings | -16,019 | -15,042 | -12,034 | -8,723 | 0 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -6,621 |
| TOTAL | $5,984 | $6,663 | $1,321 | $-391 | $1,535 |
| Total Liabilities And Equity | $6,311 | $7,113 | $2,722 | $144 | $1,761 |